BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21996677)

  • 1. Snail1 mediates hypoxia-induced melanoma progression.
    Liu S; Kumar SM; Martin JS; Yang R; Xu X
    Am J Pathol; 2011 Dec; 179(6):3020-31. PubMed ID: 21996677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
    Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
    J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1.
    Gao Y; Tang J; Ma X; Zhang C; Huang L; Che J; Wen Y; Zhang Y; Zhu Y; Liu T; Zhang H
    J Cell Physiol; 2023 Nov; 238(11):2546-2555. PubMed ID: 37642406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.
    Massoumi R; Kuphal S; Hellerbrand C; Haas B; Wild P; Spruss T; Pfeifer A; Fässler R; Bosserhoff AK
    J Exp Med; 2009 Jan; 206(1):221-32. PubMed ID: 19124656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
    Dang H; Ding W; Emerson D; Rountree CB
    BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
    Wang XQ; Zhang W; Lui EL; Zhu Y; Lu P; Yu X; Sun J; Yang S; Poon RT; Fan ST
    Int J Cancer; 2012 Aug; 131(3):E163-72. PubMed ID: 22052196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
    Scherbakov AM; Stefanova LB; Sorokin DV; Semina SE; Berstein LM; Krasil'nikov MA
    Exp Cell Res; 2013 Dec; 319(20):3150-9. PubMed ID: 23973669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
    Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
    Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.
    Lee YM; Lee SH; Lee KB; Nguyen MP; Lee MY; Park GH; Kwon MJ
    PLoS One; 2013; 8(12):e84520. PubMed ID: 24376819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.
    Rodríguez MI; González-Flores A; Dantzer F; Collard J; de Herreros AG; Oliver FJ
    Oncogene; 2011 Oct; 30(42):4365-72. PubMed ID: 21577210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer.
    Rönsch K; Jägle S; Rose K; Seidl M; Baumgartner F; Freihen V; Yousaf A; Metzger E; Lassmann S; Schüle R; Zeiser R; Michoel T; Hecht A
    Mol Oncol; 2015 Feb; 9(2):335-54. PubMed ID: 25277775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
    Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
    Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
    Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.